Filing Details
- Accession Number:
- 0001127602-13-018692
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-29 17:49:25
- Reporting Period:
- 2013-05-26
- Filing Date:
- 2013-05-29
- Accepted Time:
- 2013-05-29 17:49:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1376545 | G Gordon Pugh | 852 Winter St. Waltham MA 02451 | Svp, Coo & Cro, Alkermes, Inc. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2013-05-26 | 2,125 | $0.00 | 17,845 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2013-05-26 | 1,003 | $32.84 | 16,842 | No | 4 | F | Direct | |
Ordinary Shares | Acquisiton | 2013-05-28 | 4,555 | $8.55 | 21,397 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2013-05-28 | 4,555 | $33.59 | 16,842 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Restricted Stock Award | Disposition | 2013-05-26 | 2,125 | $0.00 | 2,125 | $0.00 |
Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2013-05-28 | 4,555 | $0.00 | 4,555 | $8.55 |
Ordinary Shares | Employee Stock Option (Right to Buy) | Acquisiton | 2013-05-28 | 75,000 | $0.00 | 75,000 | $33.72 |
Ordinary Shares | Restricted Stock Unit Award | Acquisiton | 2013-05-28 | 12,000 | $0.00 | 12,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct | ||
11,698 | 2019-05-26 | No | 4 | M | Direct | |
75,000 | 2014-05-28 | 2023-05-28 | No | 4 | A | Direct |
12,000 | 2014-05-28 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Ordinary Shares | 5,000 | Indirect | Gordon G. Pugh Revocable Trust - 2012 |
Ordinary Shares | 15,000 | Indirect | Nancy E. Pugh Revocable Trust - 2012 |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.06 to $33.9464. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- This award is fully vested in accordance with it's terms.
- These options are fully vested in accordance with their terms.
- Vests in 4 equal annual installments beginning on 5/28/14.